Shonan iPark, Takeda Pharmaceutical Company Limited.

[On Demand]
Shonan iPark is Japan’s global hub for life science innovation and collaboration founded in April
2018. It convenes private and public sector organizations and academic institutions that range in
business type and size, aiming to be a space where health innovation can be accelerated. As of
March 2021, iPark has more than 2,000 individuals from more than 110 pharmaceutical, next-gen
medicine, academia, AI, venture capital, and government-related organizations, which together
form a collaborative life science innovation ecosystem.
Company Type:
Privately Funded Company
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
General Manager of Shonan Health Innovation Park
Takeda Pharmaceutical Company